Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is -15.22% vs 36.03% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is -94.12% vs 294.20% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is -55.40% vs 98.83% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is 1,200.00% vs 0.00% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024
Compare Quarterly Results Of Xvivo Perfusion AB With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is -18.44% vs -3.95% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -15.22% vs 36.03% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 112.90% vs -134.07% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -94.12% vs 294.20% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -52.51% vs -34.52% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -55.40% vs 98.83% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is -74.38% vs 0.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 1,200.00% vs 0.00% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






